DOSIsoft Theranostics will participate in the Foundation for the National Institutes of Health (FNIH) Precision Dosimetry Imaging Biomarker (PDIB) Project, a three-year, $7.1 million initiative aimed at advancing standardized dosimetry in radiopharmaceutical therapy (RPT).
The PDIB Project brings together experts from government agencies, academia, medical societies, patient advocacy organizations, and industry. The project's goal is to establish standardized imaging protocols and reliable absorbed dose measurements for more consistent and personalized RPT treatment strategies.
The project is led by the FNIH, with principal investigators John Sunderland, PhD, and Professor Stephen Graves, PhD, both of the University of Iowa.
